Related Experiment Video
Updated: Jan 24, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2
1Department of Gynaecology, Provincial Hospital Affiliated to Shandong University, Jinan, China. czlidoc@sohu.com.
Objective:
Methyl-CpG-binding domain protein 2, a target gene of miR-221and miR-222, plays a crucial role in a large body of human cancers. In this study, we aim to explore the mechanism by which miR-221/222 promotes cervical cancer.
Materials And Methods:
We have analyzed mRNA expression of MeCP2 and MBD2 in cervical cancer tissues by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and examined the expression of miR-221/222 in C33A, HeLa, and CaSki cells by Western blot.
Results:
We found that the expression levels of MBD2 and MeCP2 were significantly reduced in cervical cancer samples as detected by the analysis of MeCP2 in matched tumor-normal samples of patients with cervical cancer, indicating a reduction in a significant percentage of patients. At the same time, we found that miR-221 and miR-222, which targeted MBD2, were upregulated in cervical cancer samples. To further elucidate the relation between miR-221/222 and MBD2, we used a lot of cell lines such as C33A, HeLa, and CaSki. Surprisingly, we found that the expression levels of MBD2 and MeCP2 were significantly lower in HeLa and CaSki than in C33A, as detected by qRT-PCR. Western blot analysis of MeCP2 of HeLa and CaSki was significantly lower than in C33A. MiR-221/222 was significantly higher in HeLa and CaSki than in C33A by qRT-PCR. The knockdown of miR-221/222 in HeLa and CaSki resulted in the downregulation of miR-221/222 levels, which rescued the expression levels of MBD2 and MeCP2 in HeLa and CaSki. However, transfection of miR-221/222 on C33A could upregulate the expression levels of miR-221/222 and decrease the expression levels of MBD2 and MeCP2.
Conclusions:
Our results demonstrate that the upregulated miR-221/222 promotes cervical cancer by repressing MBD2 and MeCP2.
Insights
MicroRNAs miR-221 and miR-222 promote cervical cancer by downregulating Methyl-CpG-binding domain protein 2 (MBD2) and MeCP2. Upregulated miR-221/222 represses these tumor suppressors, driving cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Methyl-CpG-binding domain protein 2 (MBD2) is a crucial gene in human cancers.
- MiR-221 and miR-222 are known to target MBD2.
- The role of miR-221/222 in cervical cancer progression requires further elucidation.
Purpose of the Study:
- To investigate the mechanism by which miR-221/222 promotes cervical cancer.
- To determine the relationship between miR-221/222, MBD2, and MeCP2 expression in cervical cancer.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to analyze mRNA expression of MBD2 and MeCP2 in cervical cancer tissues and cell lines.
- Western blot to examine protein expression of MeCP2.
- Analysis of miR-221/222 expression in cervical cancer cell lines (C33A, HeLa, CaSki).
- MiRNA knockdown and transfection experiments to assess functional impact.
Main Results:
- MBD2 and MeCP2 expression were significantly reduced in cervical cancer tissues.
- miR-221 and miR-222 were upregulated in cervical cancer samples and cell lines.
- Lower MBD2/MeCP2 and higher miR-221/222 levels were observed in aggressive cervical cancer cell lines (HeLa, CaSki) compared to C33A.
- Knockdown of miR-221/222 restored MBD2/MeCP2 levels, while miR-221/222 transfection decreased them.
Conclusions:
- Upregulated miR-221/222 directly represses MBD2 and MeCP2 expression.
- This repression by miR-221/222 is a key mechanism promoting cervical cancer development and progression.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
The Eukaryotic Promoter Region
Conservation of Protein Domains
RNA Polymerase II Accessory Proteins
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Repressed Memory

